Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise

Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise
Fisher & Paykel Healthcare's Lewis Gradon addressed shareholders at the company's AGM. (Image: Jacques Steenkamp)
Stock & Trade
Most markets have them - market darlings which are treated as all but sacrosanct investments, whose shares are placed on a pedestal and priced far above multiples of their competitors. Overowned and overbought, with fundamentals that are rarely subject to strict scrutiny.Does Fisher & Paykel Healthcare fall into this camp?Get up to date fast. Join BusinessDesk's WhatsApp channel.Its shares trade 58 times trailing earnings – nosebleed territory – which puts it at a significant premium to other blue-chip medical technolog...

More Markets

Beyond Meat rally tempts Kiwi traders
Markets

Beyond Meat rally tempts Kiwi traders

Meme stock mania puts Beyond among top traded stocks on Sharesies and Hatch.

Freightways outlook and Fonterra vote drive upbeat day
Markets Market Close

Freightways outlook and Fonterra vote drive upbeat day

Freightways shares climbed after Mark Troughear flagged easing economic headwinds.

Tom Raynel 30 Oct 2025
Me Today raises funds to be here tomorrow
Markets

Me Today raises funds to be here tomorrow

Shareholders have approved a capital raise of up to $2.59 million.

Greg Hurrell 30 Oct 2025